Ruzycki CA - Search Results

1

Characterization of dry powder inhaler performance through experimental methods.

Ruzycki CA, Tavernini S, Martin AR, Finlay WH. Ruzycki CA, et al. Adv Drug Deliv Rev. 2022 Oct;189:114518. doi: 10.1016/j.addr.2022.114518. Epub 2022 Sep 2. Adv Drug Deliv Rev. 2022. PMID: 36058349 Review.

2

The use of computational fluid dynamics in inhaler design.

Ruzycki CA, Javaheri E, Finlay WH. Ruzycki CA, et al. Expert Opin Drug Deliv. 2013 Mar;10(3):307-23. doi: 10.1517/17425247.2013.753053. Epub 2013 Jan 7. Expert Opin Drug Deliv. 2013. PMID: 23289401 Review.

3

Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.

Carrigy NB, Ruzycki CA, Golshahi L, Finlay WH. Carrigy NB, et al. Among authors: ruzycki ca. J Aerosol Med Pulm Drug Deliv. 2014 Jun;27(3):149-69. doi: 10.1089/jamp.2013.1075. J Aerosol Med Pulm Drug Deliv. 2014. PMID: 24870701 Review.

4

An In Vitro Examination of the Effects of Altitude on Dry Powder Inhaler Performance.

Ruzycki CA, Martin AR, Vehring R, Finlay WH. Ruzycki CA, et al. J Aerosol Med Pulm Drug Deliv. 2018 Aug;31(4):221-236. doi: 10.1089/jamp.2017.1417. Epub 2017 Nov 10. J Aerosol Med Pulm Drug Deliv. 2018. PMID: 29125912

5

An Exploration of Factors Affecting In Vitro Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat.

Ruzycki CA, Martin AR, Finlay WH. Ruzycki CA, et al. J Aerosol Med Pulm Drug Deliv. 2019 Dec;32(6):405-417. doi: 10.1089/jamp.2019.1531. Epub 2019 Aug 16. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 31418632

6

Combined in Vitro-in Silico Approach to Predict Deposition and Pharmacokinetics of Budesonide Dry Powder Inhalers.

Ruzycki CA, Murphy B, Nathoo H, Finlay WH, Martin AR. Ruzycki CA, et al. Pharm Res. 2020 Sep 29;37(10):209. doi: 10.1007/s11095-020-02924-7. Pharm Res. 2020. PMID: 32995953

7

Comparison of in vitro deposition of pharmaceutical aerosols in an idealized child throat with in vivo deposition in the upper respiratory tract of children.

Ruzycki CA, Golshahi L, Vehring R, Finlay WH. Ruzycki CA, et al. Pharm Res. 2014 Jun;31(6):1525-35. doi: 10.1007/s11095-013-1258-2. Epub 2014 Jan 7. Pharm Res. 2014. PMID: 24395403

8

An Apparatus to Deliver Mannitol Powder for Bronchial Provocation in Children Under Six Years Old.

Tang P, Leung SS, Hor E, Ruzycki CA, Carrigy NB, Finlay WH, Brannan JD, Devadason S, Anderson SD, Sly PD, Samnick K, Chan HK. Tang P, et al. Among authors: ruzycki ca. J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):452-61. doi: 10.1089/jamp.2015.1208. Epub 2015 Apr 6. J Aerosol Med Pulm Drug Deliv. 2015. PMID: 25844950

9

Amorphous pullulan trehalose microparticle platform for respiratory delivery.

Carrigy NB, Ordoubadi M, Liu Y, Melhem O, Barona D, Wang H, Milburn L, Ruzycki CA, Finlay WH, Vehring R. Carrigy NB, et al. Among authors: ruzycki ca. Int J Pharm. 2019 May 30;563:156-168. doi: 10.1016/j.ijpharm.2019.04.004. Epub 2019 Apr 2. Int J Pharm. 2019. PMID: 30951858

10

Size-Specific Filtration Performance of N95 Respirators After Decontamination by Moist Heat Incubation.

Seo S, Ruzycki CA, Johnson B, Wang H, Vehring R, Romanyk D, Finlay WH, Martin AR. Seo S, et al. Among authors: ruzycki ca. J Aerosol Med Pulm Drug Deliv. 2022 Jan;35(1):41-49. doi: 10.1089/jamp.2021.0002. Epub 2021 Aug 9. J Aerosol Med Pulm Drug Deliv. 2022. PMID: 34374572

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page